Eitan Kerem

16.1k total citations · 3 hit papers
263 papers, 10.0k citations indexed

About

Eitan Kerem is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Surgery. According to data from OpenAlex, Eitan Kerem has authored 263 papers receiving a total of 10.0k indexed citations (citations by other indexed papers that have themselves been cited), including 192 papers in Pulmonary and Respiratory Medicine, 46 papers in Epidemiology and 28 papers in Surgery. Recurrent topics in Eitan Kerem's work include Cystic Fibrosis Research Advances (146 papers), Neonatal Respiratory Health Research (72 papers) and Tracheal and airway disorders (44 papers). Eitan Kerem is often cited by papers focused on Cystic Fibrosis Research Advances (146 papers), Neonatal Respiratory Health Research (72 papers) and Tracheal and airway disorders (44 papers). Eitan Kerem collaborates with scholars based in Israel, United States and United Kingdom. Eitan Kerem's co-authors include Batsheva Kerem, Henry Levison, David Shoseyov, Malena Cohen‐Cymberknoh, Mary Corey, Joseph Reisman, Lea Bentur, Gerard J. Canny, Michael Wilschanski and Joseph Rivlin and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Eitan Kerem

251 papers receiving 9.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prediction of Mortality in Patients with Cystic Fibrosis

1992 731 citations Eitan Kerem et al. profile →
The Relation between Genotype and Phenotype in Cystic Fibrosis — Analysis of the Most Common Mutation (ΔF₅₀₈)

1990 560 citations Eitan Kerem, Batsheva Kerem et al. profile →
Tezacaftor–Ivacaftor in Residual-Function Heterozygotes with Cystic Fibrosis

2017 364 citations Eitan Kerem, Jane C. Davies et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Eitan Kerem	7.1k	1.8k	1.4k	1.2k	1.1k	263	10.0k
K. De Boeck	7.0k 1.0×	1.4k 0.8×	1.0k 0.8×	755 0.6×	1.2k 1.1×	250	8.9k
Isabelle Sermet‐Gaudelus	6.8k 1.0×	1.6k 0.9×	1.9k 1.4×	652 0.6×	897 0.8×	259	10.1k
Frank J. Accurso	9.9k 1.4×	2.0k 1.1×	1.8k 1.3×	1.0k 0.9×	1.3k 1.2×	191	12.5k
Bruce C. Marshall	10.0k 1.4×	1.5k 0.8×	2.5k 1.8×	1.3k 1.1×	943 0.9×	138	13.2k
James R. Yankaskas	6.7k 0.9×	3.5k 2.0×	1.1k 0.8×	1.1k 0.9×	965 0.9×	103	10.8k
Mary Corey	8.7k 1.2×	1.1k 0.6×	1.5k 1.1×	1.8k 1.5×	1.1k 1.0×	156	11.7k
Elizabeth Tullis	6.4k 0.9×	1.1k 0.6×	777 0.6×	995 0.8×	649 0.6×	158	8.0k
Michael W. Konstan	15.2k 2.1×	2.5k 1.4×	2.2k 1.6×	743 0.6×	2.2k 2.1×	243	18.0k
Félix Ratjen	14.9k 2.1×	2.5k 1.4×	2.2k 1.6×	1.3k 1.1×	2.8k 2.6×	452	18.1k
Pamela B. Davis	4.9k 0.7×	2.0k 1.2×	781 0.6×	518 0.4×	884 0.8×	152	7.8k

Countries citing papers authored by Eitan Kerem

Since Specialization

Citations

This map shows the geographic impact of Eitan Kerem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eitan Kerem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eitan Kerem more than expected).

Fields of papers citing papers by Eitan Kerem

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eitan Kerem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eitan Kerem. The network helps show where Eitan Kerem may publish in the future.

Co-authorship network of co-authors of Eitan Kerem

This figure shows the co-authorship network connecting the top 25 collaborators of Eitan Kerem. A scholar is included among the top collaborators of Eitan Kerem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eitan Kerem. Eitan Kerem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sermet‐Gaudelus, Isabelle, Annalisa Orenti, Elpis Hatziagorou, et al.. (2025). Health inequity in people with cystic fibrosis: can we close the gap?. Annals of the American Thoracic Society. 23(2). 228–240.

Pollak, Mordechai, Simone Gambazza, Annalisa Orenti, et al.. (2025). Respiratory infections after elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis: analysis of the European Cystic Fibrosis Society Patient Registry. ERJ Open Research. 11(4). 1248–2024. 2 indexed citations

Pollak, Mordechai, Simone Gambazza, Annalisa Orenti, et al.. (2025). Factors associated with sustained Pseudomonas aeruginosa infection following elexacaftor/tezacaftor/ivacaftor treatment: Real-world data from the European cystic fibrosis society patient registry. Journal of Cystic Fibrosis. 24(6). 1098–1104.

Kerem, Eitan, et al.. (2024). Cystic fibrosis in Europe: improved lung function and longevity – reasons for cautious optimism, but challenges remain. European Respiratory Journal. 63(3). 2301241–2301241. 15 indexed citations

Pohunek, Petr, Susanne J. H. Vijverberg, Julia Carlens, et al.. (2024). ERS statement on transition of care in childhood interstitial lung diseases. European Respiratory Journal. 64(2). 2302160–2302160. 4 indexed citations

Cohen‐Cymberknoh, Malena, Hannah Blau, Huda Mussaffi, et al.. (2023). The association between Attention-Deficit-Hyperactivity-Disorder (ADHD) symptoms and disease severity in people with Cystic Fibrosis (pwCF). Journal of Cystic Fibrosis. 22(4). 772–776. 2 indexed citations

Cohen‐Cymberknoh, Malena, Eitan Kerem, Benjamin Z. Koplewitz, et al.. (2023). Acute pancreatitis in pancreatic-insufficient cystic fibrosis patients treated with CFTR modulators. Journal of Cystic Fibrosis. 22(4). 777–779. 5 indexed citations

Mei‐Zahav, Meir, et al.. (2022). Disease severity of people with cystic fibrosis carrying residual function mutations: Data from the ECFS Patient Registry. Journal of Cystic Fibrosis. 22(2). 234–247. 8 indexed citations

Kerem, Eitan, et al.. (2022). Clinical outcomes associated with Achromobacter species infection in people with cystic fibrosis. Journal of Cystic Fibrosis. 22(2). 334–343. 12 indexed citations

10.

Gileles‐Hillel, Alex, Oded Breuer, Joel Reiter, et al.. (2022). The clinical yield of bronchoscopy in the management of cystic fibrosis: A retrospective multicenter study. Pediatric Pulmonology. 58(2). 500–506. 2 indexed citations

11.

Gelman, Daniel, Ortal Yerushalmy, Sivan Alkalay‐Oren, et al.. (2021). Expanding clinical phage microbiology: simulating phage inhalation for respiratory tract infections. ERJ Open Research. 7(4). 367–2021. 7 indexed citations

12.

Cohen‐Cymberknoh, Malena, Silvia Gärtner, Joel Reiter, et al.. (2021). How abnormal is the normal? Clinical characteristics of CF patients with normal FEV₁. Pediatric Pulmonology. 56(7). 2007–2013. 5 indexed citations

13.

Gileles‐Hillel, Alex, Sharon E. Guttman, Oded Breuer, et al.. (2021). Betamethasone versus dexamethasone for inpatient preschool wheezing—A case‐control study. Pediatric Pulmonology. 56(5). 875–882.

14.

Gileles‐Hillel, Alex, Hagar Mor‐Shaked, David Shoseyov, et al.. (2020). Whole-exome sequencing accuracy in the diagnosis of primary ciliary dyskinesia. ERJ Open Research. 6(4). 213–2020. 15 indexed citations

15.

Boeck, K. De, Margarida D. Amaral, Pavel Dřevı́nek, et al.. (2020). Cystic fibrosis drug trial design in the era of CFTR modulators associated with substantial clinical benefit: stakeholders’ consensus view. Journal of Cystic Fibrosis. 19(5). 688–695. 12 indexed citations

16.

Gordon, Oren, Malena Cohen‐Cymberknoh, Joel Reiter, et al.. (2019). Giant lung cysts following necrotizing pneumonia: Resolution with conservative treatment. Pediatric Pulmonology. 54(6). 901–906. 14 indexed citations

17.

Cohen‐Cymberknoh, Malena, Ohad Atia, Alex Gileles‐Hillel, Eitan Kerem, & Joel Reiter. (2019). Sleep disorders in patients with primary ciliary dyskinesia, cystic fibrosis with and without pancreatic insufficiency. Respiratory Medicine. 151. 96–101. 9 indexed citations

18.

Rauch, Daniela, Martin Wetzke, Simone Reu, et al.. (2015). Persistent Tachypnea of Infancy. Usual and Aberrant. American Journal of Respiratory and Critical Care Medicine. 193(4). 438–447. 45 indexed citations

19.

Molin, Søren, et al.. (2012). Symposium Summaries. Pediatric Pulmonology. 47(S35). 108–222. 1 indexed citations

20.

Kerem, Batsheva, Ornit Chiba‐Falek, & Eitan Kerem. (1997). Cystic Fibrosis in Jews: Frequency and Mutation Distribution. Genetic Testing. 1(1). 35–39. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact